{{Rsnum
|rsid=10516541
|Chromosome=4
|position=107194065
|Orientation=plus
|GMAF=0.3085
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 18.5 | 53.8 | 27.7
| HCB | 8.9 | 42.2 | 48.9
| JPT | 15.9 | 38.6 | 45.5
| YRI | 0.0 | 12.7 | 87.3
| ASW | 0.0 | 0.0 | 0.0
| CHB | 8.9 | 42.2 | 48.9
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}

{{GWAS Summary
|SNP=rs10516541
|PubMedID=17903307
|Condition=Mean forced vital capacity from 2 exams
|Gene=Intergenic
|Risk Allele=
|pValue=4.00E-006
|OR=NA
|95CI=
|OA=1
}}

{{PharmGKB
|RSID=rs10516541
|Name_s=
|Gene_s=RAC1P5
|Feature=
|Evidence=PubMed ID:17903307; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS results: Framingham Heart Study genome-wide association: results for pulmonary function measures (Initial Sample Size: 1,097-1,222 individuals, depending on measure (Framingham); Replication Sample Size: NR). This variant is associated with Mean forced vital capacity from 2 exams.
|Drugs=
|Drug Classes=
|Diseases=
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA162356434
}}

{{PMID|17903293|OA=1
}} Genome-wide association with select biomarker traits in the Framingham Heart Study.

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs10516541
|overall_frequency_n=42
|overall_frequency_d=128
|overall_frequency=0.328125
|n_genomes=30
|n_genomes_annotated=0
|n_haplomes=38
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}